Navigation Links
Transdermal Hormone Replacement: Products, Players, Markets and Forecasts
Date:5/29/2012

NEW YORK, May 29, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Transdermal Hormone Replacement: Products, Players, Markets and Forecasts http://www.reportlinker.com/p0868621/Transdermal-Hormone-Replacement-Products-Players-Markets-and-Forecasts.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication

As life expectancy in the developed world increases and populations age, the incidence and associated morbidity of decreasing hormone levels have come to the forefront as a quality-of-life issue for patients and their families. For the past two decades, the healthcare industry has responded to this clinical need by developing, testing and marketing hormone replacement therapy (HRT) products. Because of their ease-of-use and dosing characteristics, drug developers are continuing to turn to transdermal delivery systems for HRT products. There are more than 40 million post-menopausal women in the United States alone, and this group is expected to grow by 50% by 2020. With the aging of the population worldwide, conditions and diseases such as menopause, osteoporosis and heart disease, which may benefit from hormone replacement therapy, are expected to become significantly more prevalent. The industry continues to attract interest in the form of new participants and products. While the global market continues to be dominated by the FDA-approved HRT products of major pharmaceutical firms, regional markets are a bit more competitive, and present unique challenges to transdermal HRT sector participants.

Highlights

· Analyzes and evaluates the global market opportunity for transdermal hormone replacement and assesses the probable impact of evolving regulatory, economic and demand factors

· Assesses transdermal products approved or in development for the delivery of therapeutic hormones

· Provides detailed descriptions of hormone replacement treatment segments, market factors, and business strategies

· Forecasts transdermal hormone replacement product demand to 2016 by geographic region and product segment

· Profiles sector companies, their product development activities, supply chain partners, business strategies, and collaboration partners

Summary of Contents

Executive Summary

Scope and DefinitionsThe Hormone Replacement Therapy MarketThe Opportunity for Transdermal Hormone Replacement Therapy

The Hormone Replacement Therapy Market Opportunity

Evolution in HRT GuidelinesRegional Factors in HRT PracticeHormone Replacement Therapy Demand Drivers Competitive LandscapeFactors Limiting Growth

Transdermal Drug Delivery Dynamics

Transdermal HRT PatchesPatch Designs and ConstructionTransdermal Patch Manufacturing and PackagingThe Patch Manufacturing EcosystemPatch EconomicsTransdermal HRT GelsTransdermal FormulationsIP and Proprietary TechnologyLimitations of Topical Gels & EmulsionsTransdermal HRT Sprays

Transdermal HRT Indications and Markets

HypoestrogenismHypogonadismMenopauseVasomotor SymptomsVaginal AtrophyPostmenopausal Osteoporosis

Transdermal HRT Product Assessments and Market Prospects

Approved Transdermal HRT ProductsEstradiol  Ascend   Azur   Bayer Healthcare   Graceway   KV Pharm   Mylan   Novartis  Watson Laboratories   Upsher-Smith  Faran SA   Janssen-Cilag  Meda   Shiseido  Solvay Estradiol Levonorgestrel  Bayer HealthcareEstradiol/Norethindrone  Novartis Testosterone  Abbott Labs   Auxilium   Endo Pharms   Teva   Watson Laboratories Development-Stage Transdermal HRT ProductsEstrogenTestosteroneOther Hormones

Transdermal Hormone Replacement Market Factors 

Regional Regulations Clinical Trials Quality and ReliabilityIndications Prescribing Guidelines and Off-Label PrescribingManaged Care and Payor InitiativesRx-to-OTC Switching

Market Forecasts

Forecast MethodologyForecasts by RegionForecasts by Drug ClassForecasts by Delivery Form FactorMarket Share Data 

Market Participant Profiles

To order this report: Drug and Medication Industry: Transdermal Hormone Replacement: Products, Players, Markets and Forecasts

More Market Research Report

Check our Industry Analysis and Insights

__________________________
Contact Nicolas: nicolasbombourg@reportlinker.com
US: (805)-652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Purdue Pharma L.P. To Present Analysis Of Butrans® (buprenorphine) Transdermal System CIII Clinical Data At American Pain Society Annual Meeting
2. Transdermal Drug Delivery - Technologies, Markets, and Companies
3. Butrans® (Buprenorphine) Transdermal System CIII Pivotal Phase 3 Data Published in the Journal of Pain and Symptom Management
4. EMKinetics Announces Start of Pivotal Trial for the TranStim™ Transdermal Neuromodulation System
5. Transdermal Drug Delivery - Technologies, Markets, and Companies
6. Zosano Pharma, Inc. and Asahi Kasei Pharma Corporation Enter Exclusive Licensing Agreement for a Weekly Transdermal Patch Formulation of Teribone™ (teriparatide acetate) for Osteoporosis
7. Results of a Pivotal Phase 3 Efficacy and Safety Study for Butrans® (Buprenorphine) Transdermal System CIII Published in The Journal of Pain
8. New Post Hoc Analyses Examined the Effects of Neupro® (Rotigotine Transdermal System) on Daytime Functioning, Daytime Symptoms, Pain and Mood in Restless Legs Syndrome
9. Post Hoc Analysis from RECOVER Study Examined Effects of Neupro® (Rotigotine Transdermal System) on Surrogate Markers of Mood and Anhedonia in Parkinsons Disease
10. Transdermal Drug Delivery - Technologies, Markets, and Companies
11. Radius, 3M Drug Delivery Systems Sign Development Agreement for Transdermal Delivery of BA058 for Treatment of Osteoporosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... With opioids commonly used for pain management for workplace ... that has led to nationwide fatalities. The synthetic opioid ... than heroin or morphine, resulting in likelihood of addiction, abuse or ... , , ... operations, Behavioral Health for HMC HealthWorks, explained the opioid drug is ...
(Date:12/6/2016)... Dec. 6, 2016  Viking Therapeutics, Inc. ("Viking") ... company focused on the development of novel therapies ... the U.S. Food and Drug Administration (FDA) has ... treatment of X-linked adrenoleukodystrophy (X-ALD).  VK0214 is a ... that selectively regulates the expression of genes believed ...
(Date:12/6/2016)... Mass. , Dec. 6, 2016  Blueprint Medicines ... discovering and developing targeted kinase medicines for patients with ... an underwritten public offering of $125,000,000 million in shares ... to grant the underwriters a 30-day option to purchase ... of its common stock in connection with the public ...
Breaking Medicine Technology:
(Date:12/7/2016)... ... December 07, 2016 , ... ... Campaign Winner in the Folio: Marketing Awards competition. Live From won in the ... in pioneering, inventive, and ultimately successful projects undertaken by the media industry’s most ...
(Date:12/7/2016)... ... 2016 , ... "ProBrand Flip allows FCPX editors to create unique logo reveals ... of Pixel Film Studios. , ProBrand Flip includes 30 flip book reveal animations. Easily ... from a variety of flip book animations. In Addition, users can modify each preset ...
(Date:12/7/2016)... ... December 07, 2016 , ... Bioelectronic ... Plus for consumers and healthcare professionals to manage chronic and acute pain. ... treatment modalities available in a single device. The announcement is part of ...
(Date:12/7/2016)... ... 2016 , ... “The Road To Restoration”: an informative and enlightening book ... a week showing of hands. “The Road To Restoration” is the creation of published ... with the brass ring that you could reach out for, and grab, on the ...
(Date:12/7/2016)... ... December 07, 2016 , ... “Walking With God: Inspirational Lessons ... will inspire the reader to be aware of God's direction in their lives. “Walking ... Sanford Smith, retired teacher and active church leader. , Sanford says, “I ...
Breaking Medicine News(10 mins):